Publication date: Dec 03, 2024
Background: Patients aged 80 years and above are at increased risk for severe COVID-19 outcomes. This study aimed to evaluate the prognostic utility of the derived neutrophil-to-lymphocyte ratio (dNLR), aspartate-aminotransferase-to-lymphocyte ratio index (ALRI), aspartate-aminotransferase-to-platelet ratio index (APRI), and systemic immune inflammation index (SII) in predicting severe disease, intensive care unit (ICU) admission, and mortality among COVID-19 patients aged 80 years and older. Methods: In this retrospective cohort study, 138 elderly patients (≥80 years) and 215 younger controls (
Open Access PDF
Concepts | Keywords |
---|---|
Aminotransferase | COVID-19 |
Basel | intensive care |
Covid | mortality |
Elderly | prediction |
Lymphocyte | SARS-CoV-2 |
Semantics
Type | Source | Name |
---|---|---|
disease | MESH | COVID-19 |
disease | IDO | role |
disease | MESH | Inflammation |
drug | DRUGBANK | Coenzyme M |
Original Article
(Visited 1 times, 1 visits today)